Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-11

Clinical Trial Update: Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method [Phase 3]

View source ↗

Summary

Phase 3 study evaluating once-weekly risedronate on tibia and radius bone microstructure in osteopenia; results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Osteopenia | Phase 3 | Status: COMPLETED | Results posted: 2012-01-11